AXM Pharma, Inc.
AXMP
$0.0001
$0.000.00%
OTC PK
06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.66M | 1.66M | 2.17M | 2.17M | -- |
Total Receivables | 5.88M | 5.88M | 6.02M | 6.02M | -- |
Inventory | 29.93M | 29.93M | 31.64M | 31.64M | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 587.50K | 587.50K | -- | -- | -- |
Total Current Assets | 38.06M | 38.06M | 39.83M | 39.83M | -- |
|
|||||
Total Current Assets | 38.06M | 38.06M | 39.83M | 39.83M | -- |
Net Property, Plant & Equipment | 62.93M | 62.93M | 56.97M | 56.97M | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | 5.83M | 5.83M | -- |
Total Assets | 102.41M | 102.41M | 104.43M | 104.43M | -- |
|
|||||
Total Accounts Payable | 11.90M | 11.90M | 19.66M | 19.66M | -- |
Total Accrued Expenses | 13.00K | 13.00K | 12.00K | 12.00K | -- |
Short-term Debt | 27.94M | 27.94M | 22.40M | 22.40M | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 14.61M | 14.61M | 16.30M | 16.30M | -- |
Total Other Current Liabilities | 14.61M | 14.61M | 16.30M | 16.30M | -- |
Total Current Liabilities | 54.45M | 54.45M | 58.36M | 58.36M | -- |
|
|||||
Total Current Liabilities | 54.45M | 54.45M | 58.36M | 58.36M | -- |
Long-Term Debt | 1.39M | 1.39M | 3.61M | 3.61M | -- |
Short-term Debt | 27.94M | 27.94M | 22.40M | 22.40M | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 55.85M | 55.85M | 61.97M | 61.97M | -- |
|
|||||
Common Stock & APIC | 8.83M | 8.83M | 8.83M | 8.83M | -- |
Retained Earnings | 34.90M | 34.90M | 30.86M | 30.86M | -- |
Treasury Stock & Other | 2.83M | 2.83M | 2.77M | 2.77M | -- |
Total Common Equity | 46.56M | 46.56M | 42.46M | 42.46M | -- |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 46.56M | 46.56M | 42.46M | 42.46M | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 46.56M | 46.56M | 42.46M | 42.46M | -- |
|